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Abstract
Background: This study aimed to evaluate the prevalence and predictors of AIDS-related complicated cryptococcal
meningitis. The outcome was complicated cryptococcal meningitis: prolonged (≥ 14 days) altered mental status,
persistent (≥ 14 days) focal neurologic findings, cerebrospinal fluid (CSF) shunt placement or death. Predictor
variable operating characteristics were estimated using receiver operating characteristic curve (ROC) analysis.
Multivariate analysis identified independent predictors of the outcome.
Results: From 1990-2009, 82 patients with first episode of cryptococcal meningitis were identified. Of these, 14
(17%) met criteria for complicated forms of cryptococcal meningitis (prolonged altered mental status 6, persistent
focal neurologic findings 7, CSF surgical shunt placement 8, and death 5). Patients with complicated cryptococcal
meningitis had higher frequency of baseline focal neurological findings, head computed tomography (CT)
abnormalities, mean CSF opening pressure, and cryptococcal antigen (CRAG) titers in serum and CSF. ROC area of
log2 serum and CSF CRAG titers to predict complicated forms of cryptococcal meningitis were comparable, 0.78
(95%CI: 0.66 to 0.90) vs. 0.78 (95% CI: 0.67 to 0.89), respectively (c
2, p = 0.95). The ROC areas to predict the
outcomes were similar for CSF pressure and CSF CRAG titers. In a multiple logistic regression model, the following
were significant predictors of the outcome: baseline focal neurologic findings, head CT abnormalities and log2 CSF
CRAG titer.
Conclusions: During initial clinical evaluation, a focal neurologic exam, abnormal head CT and large cryptococcal
burden measured by CRAG titer are associated with the outcome of complicated cryptococcal meningitis following
2 weeks from antifungal therapy initiation.
Background
Cryptococcal meningitis remains one of the leading
causes of morbidity and mortality in patients with AIDS
in resource limited settings [1]. Up to twenty percent of
patients with cryptococcal meningitis have minimal cen-
tral nervous symptoms at clinical presentation and early
diagnosis of meningitis is facilitated by use of cerebrosp-
inal fluid (CSF) cryptococcal antigen (CRAG) [2]. Cryp-
tococcal antigen availability and use are variable in
developing countries [1]. Over the last twenty years at
the University of California, San Diego (UCSD), we
occasionally cared for patients with minimal or no
symptoms related to the central nervous system, high
serum CRAG titer (as high as 1:65,536) and ultimately
fatal HIV-associated cryptococcal meningitis. This
observation prompted us to study whether serum and/
or CSF CRAG titers alone or in combination with other
baseline clinical parameters c o u l db eu s e dt oi d e n t i f y
AIDS patients at risk for complicated forms of crypto-
coccal meningitis. The study aims were to (1) establish
the prevalence of complicated cryptococcal meningitis
in our clinical cohort, (2) identify a parsimonious set of
clinical and laboratory predictors of complicated crypto-
coccal meningitis, and (3) to examine the operating
characteristics of quantitative predictors of complicated
cryptococcal meningitis.
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Study design and population
This retrospective case series of HIV-infected adults
experiencing a first episode of cryptococcal meningitis
was approved by the UCSD Human Research Protection
P r o g r a m( p r o j e c t #0 7 1 9 3 1 )a n dp e r f o r m e da tU C S D
Medical Center. All patients provided written informed
consent for the collection of samples and subsequent
analysis. This study was conducted according to the
principles expressed in the Declaration of Helsinki.
Patients needed to be either antiretroviral naive or, if
not naive, off antiretrovirals for at least eight weeks
prior to diagnosis of cryptococcal meningitis. Patients
needed to be off fluconazole or other systemic antifun-
gals at least eight weeks prior to diagnosis of cryptococ-
cal meningitis. Baseline characteristics included
epidemiological, clinical, serological, microbiological and
radiologic data for each patient collected within 48
hours of admission. Serum and CSF CRAG titers were
obtained concurrently at the time of first lumbar punc-
ture. Three reviewers independently completed case
study forms for each patient (S.K., H.J. & E.R.C). In case
of data disagreement, reconciliation was performed by
two independent reviewers (J.C & A.M.S.).
Definitions and study outcomes
First lumbar puncture was performed within 48 hours of
hospital admission and before systemic antifungal therapy
was initiated. Since CSF opening pressure as high as 28
cmH20 has been reported in normal asymptomatic indivi-
duals in the general population [3], we defined intracranial
hypertension for this study as CSF opening pressure ≥ 30
cm H20. Complicated cryptococcal meningitis, our primary
outcome, was defined by the presence of any of the follow-
ing four criteria: (1) prolonged (≥ 14 days) altered mental
status (Glasgow scale score less than 13), (2) persistent (≥
14 days) focal neurological finding, (3) placement of surgical
CSF shunt during their hospitalization and (4) death occur-
ring 48 hours after admission and during hospital stay.
Serology
We detected CRAG in serum and CSF using a commer-
cial latex agglutination assay (CALAS; Meridian
Bioscience Europe, Nice, France) which included pro-
nase treatment according to manufacturer instructions
[4]. At UCSD microbiology laboratory, samples that test
positive for CRAG in serum or blood are routinely
diluted until finding the highest dilution associated with
a 2 + or greater agglutination reaction.
Statistical analysis
Patients were categorized in two groups according to
the presence or absence of complicated cryptococcal
meningitis. Variables between meningitis groups were
compared using t-tests and Fisher’s exact tests for con-
tinuous and categorical values, respectively. Serum and
CSF CRAG operating characteristics to predict compli-
cated cryptococcal meningitis were estimated using
receiver operating characteristic curve (ROC) analysis
[5]. Log transformation was used for cryptococcal anti-
gen titers (base 2). Association between quantitative
variables was estimated using Spearman’sr h o .V a r i a b l e s
associated with the outcome in bivariate analysis (p <
0.05) were entered into a multivariate logistic regression
model to identify independent predictors of the out-
come. For multivariate analysis intracranial hypertension
was entered as a categorical variable because initial CSF
opening pressure was not recorded for all patients. The
opening pressure variable was coded as: ≥ 30 cm of
H20, < 30 cm of H20, and not recorded. Two way inter-
actions were explored. Analysis was performed using
Stata version 11.0 (Stata Corp., College Station, Texas,
USA).
Results
Between 1 January 1990 and 31 August 2009, 156
patients were admitted with AIDS-related cryptoccocal
meningitis at UCSD. Seventy four were excluded from
the study: 40 had recurrent episodes of cryptococcal
meningitis, 11 were taking antiretrovirals, 13 had no
CRAG available, and 10 left against medical advice
within three days of admission. Eighty-two patients with
first episode of cryptococcal meningitis comprised the
study population: 93% were male; 63% were non-white.
By HIV transmission risk factor, 60% were men having
sex with men and 11% were injection drug users.
Fourteen patients (17%) met criteria for complicated
cryptococcal meningitis (death 5, prolonged altered
mental status 6, focal neurologic findings 7, CSF surgical
shunt placement 8), Table 1. All patients with compli-
cated cryptococcal meningitis were treated with Ampho-
tericin B deoxycholate (AmpBd) and 5-Fluorocytosine
(5-FC) during the induction phase (or for as long as
they survived) followed by oral fluconazole 800 mg dur-
ing the consolidation phase. However four patients were
treated with monotherapy during the first 48 hours of
hospitalization (only fluconazole 2, and only AmpBd 2).
The patients who received only fluconazole during the
first 48 hours had no initial symptoms referable to the
central nervous symptoms. All deaths occurred during
the first week of hospitalization (median: day 6, range:
day 4 to 7) and the patients who survived remain alive
for at least 6 months after outpatient follow up. Most
patients who required a CSF surgical shunt placement
had the intervention done during their third week of
hospitalization (median: day 21, range: day 5 to 30). The
Cachay et al. AIDS Research and Therapy 2010, 7:29
http://www.aidsrestherapy.com/content/7/1/29
Page 2 of 6one patient that had a CSF shunt placement in the first
week developed coma rapidly with signs of decortica-
tions after admission and had persistently elevated CSF
opening pressures with no clinical improvement despite
daily lumbar punctures. There was no difference in age,
gender, race/ethnicity, HIV risk factor, CD4 cell count
or HIV plasma load between patients with and without
complicated cryptococcal meningitis (Table 2). On
initial clinical evaluation, there was no difference in the
proportion of patients with meningeal signs, altered
mental status or seizures comparing patients with and
without complicated cryptoccocal meningitis (Table 2).
Patients with complicated cryptococcal meningitis had
higher frequency of baseline focal neurological findings
(50 vs. 5%, p = 0.0001), head computed tomography
(CT) abnormalities (21 vs. 2%, p = 0.03) and mean
values of CSF opening pressure, (43 vs. 27 cmH20, p =
0.0001), Table 2. All patients in the present study
underwent head CT evaluation except two who were in
the uncomplicated group (80 out of 82). The criteria for
head CT abnormalities included: (1) enlarged ventricles
consistent with hydrocephalus, (2) cerebritis and (3)
focal lesions with or without mass effect. In the compli-
cated group 3 patients had abnormal head CT findings
(cerebritis 3 and enlarged ventricles 1) whereas only one
patient had head CT abnormalities in the uncomplicated
group (focal lesion in basal ganglia without mass effect).
The focal neurologic findings found at baseline in
patients who had a complicated course were ocular
nerve palsies 4, hearing loss 2, and blindness 1. Of note,
all patients who died had normal Glasgow scale scores
on admission.
Patients with complicated forms of cryptococcal
meningitis had higher baseline CRAG titers in serum and
CSF (p = 0.001, Table 2). ROC, 95% confidence intervals
(CI) area of log2 serum CRAG to predict complicated
forms of cryptococcal meningitis was comparable to that
of log2 CSF CRAG, 0.78 (95%CI:0.66 to 0.90) vs. 0.78
(95% CI:0.67 to 0.89), respectively (c
2,p=0 . 9 5 ) .T h e
ROC areas to predict the outcome were similar for both
CSF opening pressure and log2 CSF CRAG (ROC area
difference 0.04 (95% CI -0.12 to 0.20, p = 0.64)). There
was a significant correlation between log2 CSF CRAG
and CSF opening pressure (Spearman rho = 0.42, p =
0.0003) and also between log2 serum CRAG and CSF
opening pressure (Spearman rho = 0.31, p = 0.01).
In bivariate categorical analysis, complicated forms of
cryptococcal meningitis were strongly associated with
t h ep r e s e n c eo fb a s e l i n ef o c al neurological findings
[odds ratio (OR) 21.7, 95% CI: 3.7-149.3, p = 0.00001],
CSF opening pressure ≥ 30 cm H20 (OR 4.3, 95% CI:
1.02-19, p = 0.02), log2 CSF CRAG titer (OR 1.5, 95%
CI:1.1-1.9) and head CT abnormalities (OR 17.7, 95%
CI: 1.2-944, p = 0.002). Multiple logistic regression
models identified focal neurologic findings, log2 CSF
antigen titer, and head CT abnormalities as independent
predictors of complicated cryptococcal meningitis
(Table 3). Values of CSF opening pressure were not
available in 14 patients (one with complicated and 13
without complicated course). Logistic regression models
yielded similar results when performed with and without
patients with missing CSF opening pressure values.
Although CSF opening pressure ≥ 30 cm H20w a s
strongly associated with the outcome in bivariate analy-
sis, this effect was not detected when controlling for
baseline focal neurologic deficit, CT abnormality, and
CSF antigen titer.
Discussion
The present study to assess AIDS patients at risk for
complicated forms of cryptococcal meningitis found
that: (1) focal neurologic deficit, CT imaging abnormal-
ity, and CSF CRAG at the time of initial hospital evalua-
tion independently predict the outcome of complicated
forms of cryptococcal meningitis following two weeks
from antifungal therapy.;(2) Serum and CSF CRAG as
measures of fungal burden were comparable in their
ability to discriminate between those with and without
outcome; (3) CSF CRAG and initial opening pressure
were comparable in ROC discrimination and (4) CRAG
(both serum and CSF) was moderately correlated with
initial CSF opening pressure.
Table 1 Distribution of Complicated Meningitis Outcome Components
Outcome N=1 4
Only persistent altered mental status 1
Only CSF shunting procedure 4
Persistent focal finding and CSF shunting 3
Persistent focal finding and death 1
Persistent altered mental status and death 2
Persistent altered mental status and persistent focal finding and CSF shunting 1
Persistent altered mental status and persistent focal finding and death 2
CSF, cerebrospinal fluid.
14 out 82 studied patients developed forms of AIDS-related cryptococcal meningitis.
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Page 3 of 6Table 2 Demographic, Clinical and Laboratory Characteristics of Study Patients with AIDS-Related Cryptococcal
Meningitis
All patients with
cryptococcal meningitis
Uncomplicated cryptococcal
meningitis patients
Complicated cryptococcal
meningitis patients
P
value
n=8 2 n=6 8 n=1 4
Age 38 (19 - 57) 38 (19 - 57) 36 (25-48) 0.54
Race/ethnicity
White 30(36.7) 28(41.2) 2(14.3)
Latino 31(37.8) 24(35.3) 7(50.00)
Black 17(20.7) 13(19.1) 4(28.6) 0.17
Asian 2(2.4) 1(1.5) 1(7.1)
Other 2(2.4) 2(2.9) 0
HIV risk factor
MSM 49 (59.8) 38(55.8) 11 (78.7)
Heterosexual 18 (22.0) 17 (25.0) 1 (7.1)
IVDA 13 ( 15.8) 11 (16.2) 2 (14.2) 0.51
Hemophilia 1 ( 1.2) 1 (1.5) 0
Unknown/other 1 (1.2) 1 (1.5) 0
CD4 cell count (× 10
6/l) 39.4 (2-256) 38.7 (2-256) 42.7 (3-139) 0.77
HIV plasma load, log10 copies/ml
a
5.3 (4.1-6.2) 5.3 (4.1-6.2) 5.5 (4.8-5.9) 0.48
Meningeal signs
b 12 (14.6) 8 (11.8) 4 (28.6) 0.21
Initial altered mental status
(Glasgow scale ≤ 13)
b
21 (25.6) 15 (22.1) 6 (42.9) 0.18
Focal neurological findings
b 10 (12.2) 3 (4.4) 7 (50) 0.0001
Seizures
b 5 (6.1) 3 (4.4) 2 (14.3) 0.20
CSF opening pressure (cmH20)
c 30 (5-61) 26.9 (5-57) 43.4 (15-61) 0.0001
CSF
wbc (/μl) 45.9 (0-500) 49.9 ( 0-500) 26.3 (0-210) 0.36
glucose(mg/dl) 41.5 (2-122) 40.7 ( 2-103) 45.8 (11-122) 0.34
protein (mg/dl) 77.2 (25-278) 77.9 (27-278) 73.9 ( 25-178) 0.79
CSF India ink positive 71 (88) 57 (85) 14 (100) 0.20
CSF culture positive 78 (98) 64 (97) 14 (100) 1.0
Blood culture positive for
Cryptococcus species
d
43 (75) 35 (75) 8 (80) 1.0
Baseline log 2 serum CRAG 11 (3-16) 11 (3-16) 14 (8-16) 0.001
Baseline log 2 CSF CRAG 10 (1-18) 9 (1-18) 13 (10-16) 0.001
Initial abnormal head CT
e 4 (4.9) 1 (1.5) 3 (21.4) 0.03
OUTCOMES
f
Persistent (≥ 14 days) altered
mental status
6 (7) 0 6 (43) 0.0001
Persistent (≥ 14 days) focal
neurological findings
7(9) 0 7(50) 0.0001
Required CSF surgical shunt 8 (10) 0 8 (57) 0.0001
Death 5 (6) 0 5 (36) 0.0001
Values shown are mean (range) or number of patients (%). MSM, men who have sex with men; IVDA, Intravenous drug use; CSF, cerebrospinal fluid; CRAG,
cryptococcal antigen; CT, computed tomography;
a Results available for 50 patients, 44 with uncomplicated and 6 with complicated cryptococcal meningitis.
b Symptoms assessed at the time of initial physical evaluation on the emergency department.
c Measurements in 68 patients, 53 with uncomplicated and 15 with complicated cryptococcal meningitis.
d Results available for 57 patients, 45 with uncomplicated and 12 with complicated cryptococcal meningitis.
e Not performed in 2 patients with uncomplicated cryptococcal meningitis.
f These are components of the definition of complicated meningitis
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of immune reconstitution) is often clinically character-
ized by a massive fungal burden with minimal CSF
pleocytosis but with elevated CSF pressure [6,7]. Intra-
cranial hypertension results is consequence of inflam-
matory cells invading and disrupting the architecture of
the arachnoid granulations which then facilitate block-
age of CSF reabsorption at the arachnoid granulations
by the fungal organism [8]. The present study showed
that the fungal burden correlates with CSF pressure, as
has been shown before by a clinical and a pathologic
study [8,9]. Our study adds that this association is pre-
sent irrespective of whether fungal burden is assessed
using serum or CSF CRAG. CRAG and India ink are
common markers of fungal burden [10,11]. In this study
only CRAG was associated with complicated cryptococ-
cal meningitis. Indian ink is widely available in develop-
ing countries whereas CRAG is not [1]. We believe that
the enhanced diagnostic sensitivity of antigen testing
over India ink as well as the prognostic value quantita-
tive antigen measurement demonstrated in this and
other studies provide further evidence to support wider
availability of quantitative antigen testing in developing
settings.
Although, having a baseline CSF opening pressure ≥
30 cmH20 was associated with complicated forms of
cryptococcal meningitis in bivariate analysis, it was not
significant in multivariate analysis. Nonetheless, the
severity of intracranial hypertension at baseline has been
associated with fatal outcomes within two weeks of
initiation of therapy in some studies [12], but not in all
[ 9 ] .T h i sd i f f e r e n c em a yb ee x p l a i n e db yan u m b e ro f
factors: (1) lack of statistical power to detect a meaning-
ful biological difference; (2)in those studies where no
association was found, patients were enrolled in an
aggressive CSF pressure management protocol with fre-
quent lumbar punctures if found to have intracranial
hypertension at baseline [9]; and (3) the wide distribu-
tion of normal CSF opening pressure values in the gen-
eral population [3] may preclude detection of an
association between intracranial hypertension and com-
plications of AIDS-related cryptococcal meningitis.
Nevertheless, current guidelines recommend measure-
ment of CSF pressure in every AIDS patient undergoing
clinical evaluation for meningitis [13]. We acknowledge
selection bias in ascertainment of initial opening pres-
sure. It is clear from both bivariate and multivariate
models that those with unrecorded opening pressure
had a prognosis similar to those with measured opening
pressures < 30 cm H20. We also note that in our cohort
almost thirty percent of patients who developed a com-
plicated course had no focal neurologic findings and
only minimal central nervous system referable symp-
toms at time of presentation.
Death is not the only relevant outcome of this oppor-
tunistic infection [14]. Our definition of complicated
cryptococcal meningitis includes death but also incorpo-
rates two elements of long term morbidity: (1) persis-
tently (≥ 14 days) abnormal neurologic exam either by
altered mental status or focal neurologic findings, and
(2) surgical intervention to control intractable intracra-
nial hypertension.
This was an observational retrospective study and
important limitations need to be recognized. First,
fourteen patients had no baseline opening CSF pres-
sure measurement. Among those who had no CSF
pressure documented, all but one had an uncompli-
cated course. The main reasons for missing CSF pres-
sure documentation included: technical challenges that
arose during lumbar puncture while performed in the
emergency room and the illness episode occurred
between 1990 and 1995 when routine measurement of
CSF opening pressure was not as widely accepted as
currently. Second, certain variables (Table 1) have
missing data: (1) HIV viral loads were missing in 39%
of patients, most of them diagnosed when viral loads
were not widely available for patient care; (2) fungal
blood cultures were not available in 17% of patients,
which is due to the observational and retrospective
nature of the study.
Table 3 Unadjusted and Adjusted Risk Factors for Developing Complicated Cryptococcal Meningitis within Two Weeks
of Admission
Risk Factor Unadjusted OR (95% CI) p Adjusted OR (95% CI) p
Baseline focal neurologic findings 21.7(3.7-149.3) .00001 17.2(2.6-114.9) .003
CSF opening pressure
a .04 .44
≥ 30 cmH20 4.3(1.2-15.1) .03 1.9(0.36-10.7) .44
Missing CSF opening pressure
b 0.6(0.1-5.8) .67 0.37(0.02-6.7) .51
Baseline log2 CSF CRAG 1.5(1.1-1.9) .004 1.5(1.1-2.2) .02
Initial abnormal head CT 17.7(1.2-944) .002 32.6(1.1-927.8) .04
a Reference < 30 cm H20
bFourteen patients have no baseline CSF opening pressure measurement
OR , Odds ratio; CI, Confidence interval; CSF, cerebrospinal fluid; CRAG, cryptococcal antigen; CT, computed tomography.
Model N = 80, ROC area 0.92, Hosmer-Lemeshow c
2 p < 0.00001
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In summary, a focal neurologic exam, abnormal head
CT, and large cryptococcal burden measured by CRAG
assessed within 48 hours of admission are associated
with the outcome of complicated forms of cryptococcal
meningitis assessed 2 weeks from antifungal therapy
initiation. These findings underscore the importance of
quantitative CRAG testing in AIDS patients with sus-
pected cryptococcal meningitis, particularly in resource
limited settings where the burden of cryptococcal
meningitis is high and access to this technology is
limited.
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